Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.

Antineoplastic Combined Chemotherapy Protocols/administration & dosage,therapeutic use Biomarkers, Tumor/analysis Breast Neoplasms/chemistry,drug therapy,genetics Cyclophosphamide/administration & dosage Female Fluorouracil/administration & dosage Humans Ki-67 Antigen/analysis Methotrexate/administration & dosage Receptor, ErbB-2/analysis,genetics Receptors, Estrogen/analysis,genetics Receptors, Progesterone/analysis,genetics Treatment Outcome

Biomarkers, Tumor Ki-67 Antigen Receptors, Estrogen Receptors, Progesterone Cyclophosphamide ERBB2 protein, human Receptor, ErbB-2 Fluorouracil Methotrexate

CMF regimen (Protocol)